178 related articles for article (PubMed ID: 29895360)
1. High spatial resolution LA-ICP-MS demonstrates massive liver copper depletion in Wilson disease rats upon Methanobactin treatment.
Müller JC; Lichtmannegger J; Zischka H; Sperling M; Karst U
J Trace Elem Med Biol; 2018 Sep; 49():119-127. PubMed ID: 29895360
[TBL] [Abstract][Full Text] [Related]
2. Spatial investigation of the elemental distribution in Wilson's disease liver after d-penicillamine treatment by LA-ICP-MS.
Hachmöller O; Zibert A; Zischka H; Sperling M; Groba SR; Grünewald I; Wardelmann E; Schmidt HH; Karst U
J Trace Elem Med Biol; 2017 Dec; 44():26-31. PubMed ID: 28965585
[TBL] [Abstract][Full Text] [Related]
3. Investigating the influence of standard staining procedures on the copper distribution and concentration in Wilson's disease liver samples by laser ablation-inductively coupled plasma-mass spectrometry.
Hachmöller O; Aichler M; Schwamborn K; Lutz L; Werner M; Sperling M; Walch A; Karst U
J Trace Elem Med Biol; 2017 Dec; 44():71-75. PubMed ID: 28965603
[TBL] [Abstract][Full Text] [Related]
4. Methanobactin reverses acute liver failure in a rat model of Wilson disease.
Lichtmannegger J; Leitzinger C; Wimmer R; Schmitt S; Schulz S; Kabiri Y; Eberhagen C; Rieder T; Janik D; Neff F; Straub BK; Schirmacher P; DiSpirito AA; Bandow N; Baral BS; Flatley A; Kremmer E; Denk G; Reiter FP; Hohenester S; Eckardt-Schupp F; Dencher NA; Adamski J; Sauer V; Niemietz C; Schmidt HH; Merle U; Gotthardt DN; Kroemer G; Weiss KH; Zischka H
J Clin Invest; 2016 Jul; 126(7):2721-35. PubMed ID: 27322060
[TBL] [Abstract][Full Text] [Related]
5. The biogenic methanobactin is an effective chelator for copper in a rat model for Wilson disease.
Summer KH; Lichtmannegger J; Bandow N; Choi DW; DiSpirito AA; Michalke B
J Trace Elem Med Biol; 2011 Jan; 25(1):36-41. PubMed ID: 21242075
[TBL] [Abstract][Full Text] [Related]
6. Element bioimaging of liver needle biopsy specimens from patients with Wilson's disease by laser ablation-inductively coupled plasma-mass spectrometry.
Hachmöller O; Aichler M; Schwamborn K; Lutz L; Werner M; Sperling M; Walch A; Karst U
J Trace Elem Med Biol; 2016 May; 35():97-102. PubMed ID: 27049132
[TBL] [Abstract][Full Text] [Related]
7. ARBM101 (Methanobactin SB2) Drains Excess Liver Copper via Biliary Excretion in Wilson's Disease Rats.
Einer C; Munk DE; Park E; Akdogan B; Nagel J; Lichtmannegger J; Eberhagen C; Rieder T; Vendelbo MH; Michalke B; Wimmer R; Blutke A; Feuchtinger A; Dershwitz P; DiSpirito AM; Islam T; Castro RE; Min BK; Kim T; Choi S; Kim D; Jung C; Lee H; Park D; Im W; Eun SY; Cho YH; Semrau JD; Rodrigues CMP; Hohenester S; Damgaard Sandahl T; DiSpirito AA; Zischka H
Gastroenterology; 2023 Jul; 165(1):187-200.e7. PubMed ID: 36966941
[TBL] [Abstract][Full Text] [Related]
8. Microbial peptide de-coppers mitochondria: implications for Wilson disease.
Kaler SG
J Clin Invest; 2016 Jul; 126(7):2412-4. PubMed ID: 27322063
[TBL] [Abstract][Full Text] [Related]
9. Wilson disease - currently used anticopper therapy.
Członkowska A; Litwin T
Handb Clin Neurol; 2017; 142():181-191. PubMed ID: 28433101
[TBL] [Abstract][Full Text] [Related]
10. A microbial peptide to rescue severe and fulminant Wilson disease?
Erlinger S
Clin Res Hepatol Gastroenterol; 2016 Dec; 40(6):647-649. PubMed ID: 27743981
[TBL] [Abstract][Full Text] [Related]
11. Update on the Diagnosis and Management of Wilson Disease.
Roberts EA
Curr Gastroenterol Rep; 2018 Nov; 20(12):56. PubMed ID: 30397835
[TBL] [Abstract][Full Text] [Related]
12. A High-Calorie Diet Aggravates Mitochondrial Dysfunction and Triggers Severe Liver Damage in Wilson Disease Rats.
Einer C; Leitzinger C; Lichtmannegger J; Eberhagen C; Rieder T; Borchard S; Wimmer R; Denk G; Popper B; Neff F; Polishchuk EV; Polishchuk RS; Hauck SM; von Toerne C; Müller JC; Karst U; Baral BS; DiSpirito AA; Kremer AE; Semrau J; Weiss KH; Hohenester S; Zischka H
Cell Mol Gastroenterol Hepatol; 2019; 7(3):571-596. PubMed ID: 30586623
[TBL] [Abstract][Full Text] [Related]
13. Wilson disease.
Kitzberger R; Madl C; Ferenci P
Metab Brain Dis; 2005 Dec; 20(4):295-302. PubMed ID: 16382340
[TBL] [Abstract][Full Text] [Related]
14. Quantitative bioimaging of copper in frozen liver specimens from cats using laser ablation-inductively coupled plasma-mass spectrometry.
Yamkate P; Funke S; Steiger K; Gold RM; Lidbury JA; Karst U; Steiner JM
J Feline Med Surg; 2023 Jul; 25(7):1098612X231186919. PubMed ID: 37522313
[TBL] [Abstract][Full Text] [Related]
15. Wilson's disease: clinical, genetic and pharmacological findings.
Leggio L; Addolorato G; Abenavoli L; Gasbarrini G
Int J Immunopathol Pharmacol; 2005; 18(1):7-14. PubMed ID: 15698506
[TBL] [Abstract][Full Text] [Related]
16. Update on Wilson disease.
Aggarwal A; Bhatt M
Int Rev Neurobiol; 2013; 110():313-48. PubMed ID: 24209444
[TBL] [Abstract][Full Text] [Related]
17. Wilson Disease: Epigenetic effects of choline supplementation on phenotype and clinical course in a mouse model.
Medici V; Kieffer DA; Shibata NM; Chima H; Kim K; Canovas A; Medrano JF; Islas-Trejo AD; Kharbanda KK; Olson K; Su RJ; Islam MS; Syed R; Keen CL; Miller AY; Rutledge JC; Halsted CH; LaSalle JM
Epigenetics; 2016 Nov; 11(11):804-818. PubMed ID: 27611852
[TBL] [Abstract][Full Text] [Related]
18. Wilson disease.
Guindi M
Semin Diagn Pathol; 2019 Nov; 36(6):415-422. PubMed ID: 31421978
[TBL] [Abstract][Full Text] [Related]
19. Hepatic features of Wilson disease.
Boga S; Ala A; Schilsky ML
Handb Clin Neurol; 2017; 142():91-99. PubMed ID: 28433114
[TBL] [Abstract][Full Text] [Related]
20. Treatment with D-penicillamine or zinc sulphate affects copper metabolism and improves but not normalizes antioxidant capacity parameters in Wilson disease.
Gromadzka G; Karpińska A; Przybyłkowski A; Litwin T; Wierzchowska-Ciok A; Dzieżyc K; Chabik G; Członkowska A
Biometals; 2014 Feb; 27(1):207-15. PubMed ID: 24368744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
